Pharmacoeconomic Analysis of Two Azithromycin Therapeutic Schemes for Lower Respiratory Tract Infections
- VernacularTitle:阿奇霉素治疗下呼吸道感染两种方案的药物经济学评价
- Author:
Pengfei YANG
;
Erjiang YE
;
Qiang LIU
;
Juan LIAO
- Publication Type:Journal Article
- Keywords:
azithromycin;
lower respiratory tract infection;
pharmacoeconomics
- From:
China Pharmacy
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the economic effects of two azithromycin therapeutic schemes for lower respiratory tract infections(LRTI).METHODS:45cases of LRTI collected from this hospital were divided into two groups:iv azithromycin group and iv oral sequential azithromycin group.Clinical effect was observed and cost-effectiveness analysis was carried out.RESULTS:The total costs were415.00yuan and260.08yuan(P0.05)in iv azithromycin group and iv oral sequential group respectively.CONCLUSION:The iv oral sequential azithromycin scheme is better one for treating LRTI.
